Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ly1 Antibody Reactive (LYAR) (Middle Region) Peptide

LYAR Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN979660

Aperçu rapide pour Ly1 Antibody Reactive (LYAR) (Middle Region) Peptide (ABIN979660)

Antigène

LYAR (Ly1 Antibody Reactive (LYAR))

Origine

Humain

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-LYAR antibody (Catalog #: ARP57042_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    LYAR (Ly1 Antibody Reactive (LYAR))

    Classe de substances

    Antibody

    Sujet

    The function of this protein remains unknown.

    Alias Symbols: FLJ20425, ZLYAR

    Protein Interaction Partner: ZBTB16,ZHX1,BRIX1,DDX21,DDX27,DHX57,DHX9,EBNA1BP2,EIF3I,GNL2,GTPBP4,KPNA1,KRT31,KRT82,KRT85,MYBBP1A,NAT10,NPM1,RPL18A,RPL21,RPL23A,RPL3,RPL31,RPS3A,RPS9,Rrp1b,SRP14,TSR1,TWF2,ZBTB16,ZHX1

    Protein Size: 379

    Poids moléculaire

    44 kDa

    ID gène

    55646

    NCBI Accession

    NM_017816, NP_060286

    UniProt

    Q9NX58
Vous êtes ici:
Chat with us!